Explore
Trendline
SUNation Energy Reports Q3 2026 Revenue Growth Amid Residential Market Decline, Advances Suniva Merger
SUNation Energy Reports Q3 2026 Revenue Growth Amid Residential Market Decline, Advances Suniva Merger
Read More
Trendline
T. Rowe Price Group Reports Strong Q3 2026 Earnings Amidst Market Underperformance
T. Rowe Price Group Reports Strong Q3 2026 Earnings Amidst Market Underperformance
Read More
Trendline
Geospace Technologies Reports $80.7 Million FY2026 Revenue and $44.3 Million Net Loss Amidst Market Volatility
Geospace Technologies Reports $80.7 Million FY2026 Revenue and $44.3 Million Net Loss Amidst Market Volatility
Read More
Trendline
BitFuFu Reports Increased Hashrate and Self-Mining Production in Q3 2026
BitFuFu Reports Increased Hashrate and Self-Mining Production in Q3 2026
Read More
Trendline
CoreWeave Reports Strong Q3 2026 Financials Amidst International Expansion and Increased Capital Expenditure
CoreWeave Reports Strong Q3 2026 Financials Amidst International Expansion and Increased Capital Expenditure
Read More
Trendline
Williams-Sonoma, Inc. Reports Strong Q3 2026 Financial Results, Driven by Revenue Growth and Tariff Refunds
Williams-Sonoma, Inc. Reports Strong Q3 2026 Financial Results, Driven by Revenue Growth and Tariff Refunds
Read More
Trendline
Gap Inc. Reports 2% Net Sales Increase in Q3 2026, Exceeding Profit Expectations
Gap Inc. Reports 2% Net Sales Increase in Q3 2026, Exceeding Profit Expectations
Read More
Trendline
Crown Castle Reports Q3 2026 AFFO Beat Despite Revenue Decline
Crown Castle Reports Q3 2026 AFFO Beat Despite Revenue Decline
Read More
Trendline
Vivmark Residential Emerges from Equity Residential Merger, Faces Investor Scrutiny on Dividend Coverage
Vivmark Residential Emerges from Equity Residential Merger, Faces Investor Scrutiny on Dividend Coverage
Read More
Trendline
Tempus AI Reports Strong Q3 2026 Revenue Growth and Positive Adjusted EBITDA, Driven by Data Licensing and Regulatory Approvals
Tempus AI Reports Strong Q3 2026 Revenue Growth and Positive Adjusted EBITDA, Driven by Data Licensing and Regulatory Approvals
Read More
Trendline
Core Specialty Insurance Holdings Reports Revenue Decline Ahead of NYSE IPO Filing
Core Specialty Insurance Holdings Reports Revenue Decline Ahead of NYSE IPO Filing
Read More
Trendline
Pfizer's New Drug Revenue Surges 32% in Q3 2026 Amidst Patent Cliff Concerns
Pfizer's New Drug Revenue Surges 32% in Q3 2026 Amidst Patent Cliff Concerns
Read More